Related by context. Frequent words. (Click for all words.) 67 systemic embolism 66 cerebrovascular events 65 composite endpoint 64 myocardial infarction stroke 64 coronary revascularization 62 myocardial infarction MI 61 Secondary endpoints included 61 prespecified 61 androgen deprivation 61 unfractionated heparin 61 target vessel revascularization 60 cardiovascular hospitalization 60 confidence interval #.#-#.# 60 fibrinolysis 60 irbesartan 60 thrombolytic therapy 59 TRITON TIMI 59 fondaparinux 59 platelet inhibition 59 infarct size 59 NYHA class 59 statistically significant p = 58 cardiovascular morbidity 58 stent implantation 58 anticoagulation therapy 58 vertebral fracture 58 secondary endpoint 58 carotid intima media 58 univariate 58 acute coronary syndromes ACS 58 nonsignificant 58 cytogenetic response 58 HbA 1c 58 STEMI patients 58 myocardial infarctions 58 chemoradiotherapy 58 LVEF 58 stroke myocardial infarction 58 tolvaptan 58 Secondary endpoints include 57 thromboembolism 57 P = .# 57 undergoing coronary artery 57 achieved statistical significance 57 bivalirudin 57 plus prednisone 57 thromboembolic events 57 plus dexamethasone 57 ticagrelor 56 noninferiority 56 Amrubicin 56 acute coronary syndromes 56 CI -#.# 56 endarterectomy 56 angiotensin converting enzyme inhibitors 56 CYPHER ® Stent 56 left ventricular systolic 56 myocardial infarction 56 TIMI 56 Secondary endpoints 56 active comparator 56 mycophenolate mofetil 56 enoxaparin 56 cardiac dysfunction 56 antiplatelet agents 56 HbA1c levels 56 acute coronary syndrome 56 serum phosphorus 56 echocardiographic 56 creatinine clearance 56 T2DM 56 DAS# [002] 56 preoperatively 56 serum concentrations 56 EBRT 56 confidence interval CI 55 mg kg dose 55 laboratory abnormalities 55 antihypertensive agents 55 thrombotic events 55 D dimer 55 ADAS cog 55 glycated hemoglobin 55 venous thromboembolism VTE 55 placebo controlled clinical 55 lipid lowering therapy 55 pulmonary embolism PE 55 plus gemcitabine 55 mg BID 55 inflammatory lesions 55 glomerular filtration rate 55 sensitivity specificity 55 coronary angiography 55 eGFR 55 virologic response 55 secondary efficacy endpoints 55 left ventricular dysfunction 55 FOLFIRI 55 estimated glomerular filtration 55 mg QD 55 rotigotine